The popular medication Zantac has been recalled by its manufacturers due to the presence of NDMA (N-Nitrosodimethylamine), a probable carcinogen.
Zantac, which can be prescribed or purchased over-the-counter, is one of the most widely used drugs in the United States. Since 1983, it has been taken by millions of people who suffer from ulcers, hernias, heartburn, acid indigestion, and other ailments.
If you’ve been diagnosed with cancer after using Zantac and believe the drug may have been the cause, you could be entitled to file a claim against Zantac’s manufacturers.
What is NDMA?
NDMA is a semivolatile organic chemical that forms in both industrial and natural processes. It has been classified as a probable carcinogen by US government agencies.
The presence of NDMA was recently found in Zantac’s active ingredient ranitidine during tests by the FDA, prompting voluntary recalls by Zantac manufacturers.
How much NDMA does Zantac contain?
In some tests, a single tablet of Zantac was found to contain 3,000,000 nanograms of NDMA, which far exceeds the FDA’s maximum acceptable daily intake of 96 ng.
The pharmaceutical companies that manufacture Zantac and its generic versions knew or should have known about the presence of NDMA in the product prior to the FDA’s finding. However, they failed to adequately warn users or the medical community, even though the chemical’s probable risks have been known for decades.
Lawsuits allege that Zantac manufacturers:
- Failed to adequately research possible side effects of Zantac
- Knew or should have known that Zantac contains NDMA
- Failed to warn users or the medical community about Zantac’s potential cancer risks
- Declined to promptly issue Zantac recalls or safety warnings
- Allowed consumers to unknowingly purchase and consume a product which carried cancer risks
What kind of cancer is NDMA linked to?
Studies have found that NDMA likely leads to a higher risk of certain cancers, including but not necessarily limited to:
- Bladder cancer
- Colon cancer
- Esophageal cancer
- Kidney cancer
- Liver cancer
- Lung cancer
- Pancreatic cancer
- Rectal cancer
- Stomach cancer
- Uterine cancer
Here’s what various government agencies have said about NDMA’s probable link to cancer:
- NDMA is a probable human carcinogen based on results from laboratory tests – Food and Drug Administration (FDA)
- It is “reasonable to expect that exposure to NDMA by eating, drinking, or breathing could cause cancer in humans” – Centers for Disease Control and Prevention (CDC)
- NDMA is a B2 (probable human) carcinogen based on the induction of tumors at multiple sites in different mammal species exposed to the chemical – Environmental Protection Agency (EPA)
- NDMA is “probably carcinogenic to humans” – World Health Organization (WHO)
If you or a family member have been diagnosed with any of the cancers listed above after taking Zantac, contact McWhirter, Bellinger & Associates right away.
You could be entitled to receive compensation for:
- Medical bills
- Pain and suffering
- Disability or permanent injury
- Lost wages/loss of earning capability
- Punitive damages
- Rehabilitation costs
- Wrongful death
Our lawyers are highly experienced and ready to give you a free case evaluation. Call us today at 888-353-5513.